A native of Manchester, England, Dr. Lee earned his PhD from the University of Newcastle-upon-Tyne and subsequently held postdoctoral research fellowship positions at Colorado State University and the University of Oxford. After appointments at the National Institutes of Health and the University of Tennessee Health Science Center, College of Pharmacy, he joined the Department of Chemical Biology & Therapeutics at St. Jude in 2009, and holds the Endowed Chair in Medicinal Chemistry. Dr. Lee's research focuses on medicinal chemistry and structure-based drug design, with an emphasis on inhibitors to treat drug-resistant bacterial infections. His research program's impact can be seen in nearly a dozen patents, more than 160 peer-review publications, and the advancement of two of his drug candidates into clinical trials. Dr. Lee is the co-director of the St. Jude NIH-supported T32 Infectious Disease Therapeutics Postdoctoral Training Program.